Originally developed at Cambridge University, CANTABTM technology has been continually enhanced by Cambridge Cognition for over a decade. CANTABTM technology has been extensively used in research, resulting in over 2,300 peer-reviewed research papers, more than any other computerized cognitive test. These include nearly three hundred publications in neurodegenerative inflammatory disorders. The technology includes secure, cloud-based servers for data storage and study management. The company has an excellent track record of translating neuroscience research into successful products for healthcare and clinical research. Cambridge Cognition have extensive experience in developing scientifically robust and engaging cognitive assessments on new technology platforms, including wearable devices, mobile phones and using automated speech recognition.